• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在随机效应成对和网络荟萃分析中纳入关于研究间异质性的真实先验信息。

Incorporating Genuine Prior Information about Between-Study Heterogeneity in Random Effects Pairwise and Network Meta-analyses.

机构信息

School of Health and Related Research, University of Sheffield, Sheffield, England, UK.

School of Mathematics and Statistics, University of Sheffield, Sheffield, England, UK.

出版信息

Med Decis Making. 2018 May;38(4):531-542. doi: 10.1177/0272989X18759488. Epub 2018 Mar 29.

DOI:10.1177/0272989X18759488
PMID:29596031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5950028/
Abstract

BACKGROUND

Pairwise and network meta-analyses using fixed effect and random effects models are commonly applied to synthesize evidence from randomized controlled trials. The models differ in their assumptions and the interpretation of the results. The model choice depends on the objective of the analysis and knowledge of the included studies. Fixed effect models are often used because there are too few studies with which to estimate the between-study SD from the data alone.

OBJECTIVES

The aim of this study was to propose a framework for eliciting an informative prior distribution for the between-study SD in a Bayesian random effects meta-analysis model to genuinely represent heterogeneity when data are sparse.

METHODS

We developed an elicitation method using external information, such as empirical evidence and expert beliefs, on the "range" of treatment effects to infer the prior distribution for the between-study SD. We also developed the method to be implemented in R.

RESULTS

The 3-stage elicitation approach allows uncertainty to be represented by a genuine prior distribution to avoid making misleading inferences. It is flexible to what judgments an expert can provide and is applicable to all types of outcome measures for which a treatment effect can be constructed on an additive scale.

CONCLUSIONS

The choice between using a fixed effect or random effects meta-analysis model depends on the inferences required and not on the number of available studies. Our elicitation framework captures external evidence about heterogeneity and overcomes the assumption that studies are estimating the same treatment effect, thereby improving the quality of inferences in decision making.

摘要

背景

使用固定效应和随机效应模型的成对和网络荟萃分析常用于综合随机对照试验的证据。这些模型在假设和结果解释方面存在差异。模型的选择取决于分析的目的和对纳入研究的了解。由于单独从数据中估计研究间标准差的研究太少,因此通常使用固定效应模型。

目的

本研究旨在提出一种在贝叶斯随机效应荟萃分析模型中为研究间 SD eliciting 一个信息先验分布的框架,以在数据稀疏时真正表示异质性。

方法

我们开发了一种使用外部信息(如经验证据和专家意见)的启发式方法,对“治疗效果范围”进行启发式方法,以推断研究间 SD 的先验分布。我们还开发了一种在 R 中实现的方法。

结果

3 阶段启发式方法允许通过真实的先验分布来表示不确定性,以避免产生误导性的推断。它灵活地适应专家可以提供的判断,并且适用于所有类型的可以在加性尺度上构建治疗效果的结果测量。

结论

选择使用固定效应或随机效应荟萃分析模型取决于所需的推断,而不是可用研究的数量。我们的启发式框架捕捉了关于异质性的外部证据,并克服了研究估计相同治疗效果的假设,从而提高了决策中的推断质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/db9f279197f3/10.1177_0272989X18759488-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/a73a63e94c4d/10.1177_0272989X18759488-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/70b80148fbe7/10.1177_0272989X18759488-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/5f70f68bd6be/10.1177_0272989X18759488-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/db9f279197f3/10.1177_0272989X18759488-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/a73a63e94c4d/10.1177_0272989X18759488-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/70b80148fbe7/10.1177_0272989X18759488-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/5f70f68bd6be/10.1177_0272989X18759488-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a66/5950028/db9f279197f3/10.1177_0272989X18759488-fig4.jpg

相似文献

1
Incorporating Genuine Prior Information about Between-Study Heterogeneity in Random Effects Pairwise and Network Meta-analyses.在随机效应成对和网络荟萃分析中纳入关于研究间异质性的真实先验信息。
Med Decis Making. 2018 May;38(4):531-542. doi: 10.1177/0272989X18759488. Epub 2018 Mar 29.
2
[Meta-analysis of the Italian studies on short-term effects of air pollution].[意大利关于空气污染短期影响研究的荟萃分析]
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71.
3
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.制定医疗保健决策中结构化专家 elicitation 的参考协议:混合方法研究。
Health Technol Assess. 2021 Jun;25(37):1-124. doi: 10.3310/hta25370.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial.针对存在健康结局缺失情况的随机对照试验,开发一种实用的专家意见征集方法:在IMPROVE试验中的应用。
Clin Trials. 2017 Aug;14(4):357-367. doi: 10.1177/1740774517711442. Epub 2017 Jul 4.
6
Bayesian random-effects meta-analysis with empirical heterogeneity priors for application in health technology assessment with very few studies.具有经验异质性先验的贝叶斯随机效应荟萃分析,适用于研究数量极少的卫生技术评估。
Res Synth Methods. 2024 Mar;15(2):275-287. doi: 10.1002/jrsm.1685. Epub 2023 Dec 28.
7
Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis.总结贝叶斯随机效应荟萃分析中研究间异质性的经验信息。
Stat Med. 2023 Jun 30;42(14):2439-2454. doi: 10.1002/sim.9731. Epub 2023 Apr 2.
8
A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta-analysis.一种用于在成对荟萃分析中处理因二元结局数据缺失而产生不确定性的贝叶斯框架。
Stat Med. 2015 May 30;34(12):2062-80. doi: 10.1002/sim.6475. Epub 2015 Mar 24.
9
Incorporating external evidence on between-trial heterogeneity in network meta-analysis.纳入网状meta 分析中试验间异质性的外部证据。
Stat Med. 2019 Apr 15;38(8):1321-1335. doi: 10.1002/sim.8044. Epub 2018 Nov 28.
10
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.仑伐替尼联合帕博利珠单抗治疗未经治疗的晚期肾细胞癌:系统评价和成本效果分析。
Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238.

引用本文的文献

1
Risk of Bias in Network Meta-Analysis (RoB NMA) tool.网状Meta分析中的偏倚风险(RoB NMA)工具
BMJ. 2025 Mar 18;388:e079839. doi: 10.1136/bmj-2024-079839.
2
Network Meta-analysis of Randomized Controlled Trials in Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: Comparisons Involving Ramucirumab.既往治疗的晚期胃癌或胃食管结合部癌患者的随机对照试验的网络 Meta 分析:涉及雷莫芦单抗的比较。
J Gastrointest Cancer. 2024 Oct 25;56(1):10. doi: 10.1007/s12029-024-01121-8.
3
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis.

本文引用的文献

1
A basic introduction to fixed-effect and random-effects models for meta-analysis.Meta 分析中固定效应模型和随机效应模型的基本介绍。
Res Synth Methods. 2010 Apr;1(2):97-111. doi: 10.1002/jrsm.12. Epub 2010 Nov 21.
2
Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis.研究间异质性的预测分布及其在贝叶斯荟萃分析中的简单应用方法。
Stat Med. 2015 Mar 15;34(6):984-98. doi: 10.1002/sim.6381. Epub 2014 Dec 5.
3
Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data.
治疗复发性多发性硬化症的疗效比较:系统评价和网络荟萃分析。
J Comp Eff Res. 2023 Jul;12(7):e230016. doi: 10.57264/cer-2023-0016. Epub 2023 Jun 2.
4
Classifying information-sharing methods.分类信息共享方法。
BMC Med Res Methodol. 2021 May 22;21(1):107. doi: 10.1186/s12874-021-01292-z.
5
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.行为修正干预对初级保健中无法用医学解释的症状:系统评价和经济评估。
Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460.
6
Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.地舒单抗、雷洛昔芬、罗莫佐单抗和特立帕肽预防骨质疏松性脆性骨折:系统评价和经济评估。
Health Technol Assess. 2020 Jun;24(29):1-314. doi: 10.3310/hta24290.
7
How to Conduct a Bayesian Network Meta-Analysis.如何进行贝叶斯网络荟萃分析。
Front Vet Sci. 2020 May 19;7:271. doi: 10.3389/fvets.2020.00271. eCollection 2020.
8
Does transcranial direct current stimulation improve functional locomotion in people with Parkinson's disease? A systematic review and meta-analysis.经颅直流电刺激是否能改善帕金森病患者的功能性运动?系统评价和荟萃分析。
J Neuroeng Rehabil. 2019 Jul 8;16(1):84. doi: 10.1186/s12984-019-0562-4.
9
Acupuncture as an Adjunctive Treatment for Angina Due to Coronary Artery Disease: A Meta-Analysis.针刺辅助治疗冠心病心绞痛的疗效评价:Meta 分析。
Med Sci Monit. 2019 Feb 16;25:1263-1274. doi: 10.12659/MSM.913379.
10
A meta-analysis: Parkinson's disease and dual-task walking.一项荟萃分析:帕金森病与双重任务行走。
Parkinsonism Relat Disord. 2019 May;62:28-35. doi: 10.1016/j.parkreldis.2018.12.012. Epub 2018 Dec 12.
预测分布被开发用于元分析连续结局数据中异质性的程度。
J Clin Epidemiol. 2015 Jan;68(1):52-60. doi: 10.1016/j.jclinepi.2014.08.012. Epub 2014 Oct 7.
4
Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis.证据综合决策 6:将证据综合嵌入概率成本效益分析中。
Med Decis Making. 2013 Jul;33(5):671-8. doi: 10.1177/0272989X13487257.
5
Evidence synthesis for decision making 5: the baseline natural history model.循证决策 5:基线自然史模型。
Med Decis Making. 2013 Jul;33(5):657-70. doi: 10.1177/0272989X13485155.
6
Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials.证据综合决策 4:基于随机对照试验的证据网络中的不一致性。
Med Decis Making. 2013 Jul;33(5):641-56. doi: 10.1177/0272989X12455847.
7
Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment.循证决策 3:异质性——亚组、Meta 回归、偏倚和偏倚调整。
Med Decis Making. 2013 Jul;33(5):618-40. doi: 10.1177/0272989X13485157.
8
Evidence synthesis for decision making 1: introduction.循证决策 1:引言。
Med Decis Making. 2013 Jul;33(5):597-606. doi: 10.1177/0272989X13487604.
9
Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.证据综合决策 2:用于随机对照试验的成对和网络荟萃分析的广义线性建模框架。
Med Decis Making. 2013 Jul;33(5):607-17. doi: 10.1177/0272989X12458724. Epub 2012 Oct 26.
10
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews.利用 Cochrane 系统评价数据库中的实证数据预测荟萃分析中的异质性程度。
Int J Epidemiol. 2012 Jun;41(3):818-27. doi: 10.1093/ije/dys041. Epub 2012 Mar 29.